Simplifying pharmacotherapy for patients with COPD: a viewpoint
Tweetable abstract Review of simple clinical and physiological data can help stratify COPD
severity and guide the pharmacotherapy most likely to improve patient outcomes …
severity and guide the pharmacotherapy most likely to improve patient outcomes …
Upfront combination of statin and ezetimibe for patients with acute coronary syndrome: time for a new approach?
Lipid-lowering therapy (LLT) is a cornerstone in the management of patients with acute
coronary syndrome (ACS). 1 Statins are 3-hydroxy-3-methy lglutaryl-coenzyme A reductase …
coronary syndrome (ACS). 1 Statins are 3-hydroxy-3-methy lglutaryl-coenzyme A reductase …
Economic burden associated with the treatment with a cardiovascular polypill in secondary prevention in Spain: Cost-effectiveness results of the NEPTUNO study
A Cordero, R Dalmau González-Gallarza… - ClinicoEconomics …, 2023 - Taylor & Francis
Purpose The aim of this study was to estimate health-care resources utilization, costs and
cost-effectiveness associated with the treatment with CNIC-Polypill as secondary prevention …
cost-effectiveness associated with the treatment with CNIC-Polypill as secondary prevention …
[HTML][HTML] The effectiveness of polypill for the prevention of cardiovascular disease: a meta-analysis of randomized controlled trials
GS Virk, A Sharma, MR Khan, K Shah, J Mengar… - Cureus, 2023 - ncbi.nlm.nih.gov
A significant global health concern, cardiovascular disease (CVD) is characterized by a
rising prevalence and accompanying mortality rates. It is crucial to implement primary and …
rising prevalence and accompanying mortality rates. It is crucial to implement primary and …
Present and future of dyslipidaemia treatment—a review
I Merćep, A Vujević, D Strikić, I Radman, I Pećin… - Journal of Clinical …, 2023 - mdpi.com
One of the greatest burdens on the healthcare systems of modern civilization is
cardiovascular diseases (CVDs). Therefore, the medical community is looking for ways to …
cardiovascular diseases (CVDs). Therefore, the medical community is looking for ways to …
Association Between Self‐Rated Medication Adherence and Adverse Cardiovascular Outcomes in Patients With Hypertension
Background Medication nonadherence contributes to poor health outcomes but remains
challenging to identify. This study assessed the association between self‐rated adherence …
challenging to identify. This study assessed the association between self‐rated adherence …
[HTML][HTML] Estándares de la Sociedad Española de Arteriosclerosis 2024 para el control global del riesgo vascular
Resumen La Sociedad Española de Arteriosclerosis (SEA) tiene entre sus objetivos
contribuir al conocimiento, prevención y tratamiento de las enfermedades vasculares, que …
contribuir al conocimiento, prevención y tratamiento de las enfermedades vasculares, que …
Effectiveness of polypill for primary and secondary prevention of cardiovascular disease: a pragmatic cluster-randomised controlled trial (PolyPars)
Background We aimed to investigate the effectiveness of fixed-dose combination therapy
(polypill) for primary and secondary prevention of major cardiovascular diseases in a typical …
(polypill) for primary and secondary prevention of major cardiovascular diseases in a typical …
Highlights of cardiovascular disease prevention studies presented at the 2022 European Society of Cardiology Congress
Abstract Purpose of Review Focused review of select studies presented at the 2022
European Society of Cardiology Congress. Recent Findings Included studies assessed the …
European Society of Cardiology Congress. Recent Findings Included studies assessed the …
A SECURE polypill as a strategy at the heart of secondary prevention
G Liuzzo, C Patrono - 2022 - academic.oup.com
• The Secondary Prevention of Cardiovascular Disease in the Elderly (SECURE), 1 a Phase
3, open-label, randomized, controlled trial that was supported by public and private …
3, open-label, randomized, controlled trial that was supported by public and private …